( 12.6% and I 3%, respectively), diet B had a relatively low amount of GLA (I .25%) whereas diet C had a higher percentage of GLA (4.63%).
To maintain a similar ratio of n-6 to n-3 PUFAs between diets B and C, LA was replaced by GLA in diet C. Vitamins C and E and n-carotene were increased in diets B and C relative to diet A to minimize the potential of lipid peroxide formation in vivo (Table  I) . 
Endotoxin infusion

Isolation of hepatic KE cells
Subsets (n = 6/group) of rats were killed on day 0 (prediet baseline), or days 3 or 6 depending on the randomization schedule.
Each rat was anesthetized with 50 mg pentobarbi- fatty acids present in the stock diet pellets (13) and the low-fat baseline diet (day-0 rats) with that present in the three enteral diets tested. For example, AM4 from rats randomly assigned to receive the LA-enriched diet (diet A) had significantly higher percentages of LA, total n-6 PUFAs, and ratios of n-6 to n-3 PUFAs by day 3 relative to rats at baseline (day 0, Table   3 ). Similarly, AM4 from rats randomly assigned to receive the diets enriched with GLA and EPA (diets B and C) had significantly higher (P < 0.001) concentrations of EPA and other n-3 PUFAs ( Figure  2a and Table  3) , and a trend toward 3.8 ± 1.8 1.6 ± 0.4 2.5 ± 1.0 2.3 ± 1.3 1.3 ± 0.7 2.0 ± 1.1 1.7 ± 1.1 (16:0) 46.4 ± 3.7 40.9 ± 6.4 39.2 ± 5.8 41.1 ± 6.3 38.5 ± 3.9 38.6 ± 1.5 39.5 ± 3.6 Palmitoleic (16:ln-7) 2.9 ± 0.8 2.4 ± 1.5 3.2 ± 4.7 1.6 ± 0.8 1.6 ± 2.2 2.2 ± 0.9 2.2 ± 1.0 Stearic (18:0) 13.4 ± 2.3 17.0 ± 2.3
Palmitic
15.5 ± 1.9 16.3 ± 2.4 16.9 ± 2.3 16.8 ± 1.8 16.5 ± 1.2
Oleic (l8:ln-9) 6.5 ± 0.9 6.9 ± 0.6" 8.4 ± 1.4" 9.3 ± 0.7" 7.8 ± 2.0 9.1 ± 1.8 9.1 ± 0.7 Linoleic (18:2n-6) 5.6 ± 1.6 1 1.4 ± 0.8" 6.2 ± 0.7" 6.0 ± 0.5" 1 1.9 ± 0.9" 6.3 ± 0.5" 5.3 ± 0.5c 1.7 ± 0.6 0.4 ± 0.5" 2.9 ± 0.4" 2.8 ± 0.7" 0.2 ± 0.3" 3.0 ± 0.9" 2.8 ± 0.8" Docosahexaenoic (22:6n-3) 3.5 ± 0.9 1.7 ± 1.1" 4.6 ± 0.8" 4.7 ± 1.0" 1.8 ± 0.9" 5.0 ± 1.1" 4.8 ± 1.3"
Docosapentaenoic
Total saturates 65.1 ± 3.7
60.5 ± 4.8 58.2 ± 5.2 60.4 ± 6.0 58.1 ± 2.9 59.1 ± 2.4 59.0 ± 4.4
Total monounsaturates 10.6 ± 1.8
11.6 ± 3.4 13.4 ± 3.6 12.0 ± 2.0 11.8 ± 2.7 12.4 ± 2.0 12.5 ± 0.9
Total n-3 polyunsaturates 6.2 ± 1.8 2.1 ± 1.4" 11.1 ± 2.2" 10.1 ± 2.9" 2.9 ± 1.8" 11.3 ± 2.3" 10.8 ± 3.1" Total n-6 polyunsaturates 17.4 ± 2.9 25.7 ± 2.8" 17.3 ± 1.2" 17.2 ± 2.2" 27.0 ± 2.3" 17.0 ± 1.4" 17.6 ± 19b n-6:n-3 3.0 ± 0.9 9.0 ± 0.9" 1.6 ± 0.3" 1.8 ± 0.4" 8.9 ± 3.3" 1.6 ± 0.5" 1.7 ± 0. 22:Sn-3), and DHA (Table  3) in AM4 from rats receiving diets B and C were significantly higher, and AA ( Figure  3 ) and LA (Table 3) were concurrently lower on both days 3 and 6. In accordance with these modifications, total n -3 PUFAs were significantly higher (P < 0.001) whereas total n -6 PUFAs and ratios of n-6 to n-3 PUFAs were lower in AM4 from rats infused with diets B or C relative to those given diet A (Table 3 ). Of interest was the finding that the rats receiving the higher-GLA diet (diet C) had significantly lower amounts of LA on day 6 than did the rats receiving the low-GLA diet (diet B) ( Oleic(18:ln-9) 11.2±0.8 11.1 ±0.6" 12.7± 1.1" 13.3±0.? 11.2±0.8" 13.2±0.3" 13.8±0.4" Linoleic (18:2n-6) 9.2 ± 1.0 11.4 ± 0.9" 7.9 ± 0.5" 7.1 ± 0.6" 11.6 ± 0.4" 7.6 ± 0.3" 6.5 ± 0.2 Docosapentaenoic (22:Sn-3)
2.4 ± 0.6
1.3 ± 0.3" 3.6 ± 0.2" 3.5 ± 0.6" 1.0 ± 0.2" 3.7 ± 0.7" 3.6 ± 0.6" Docosahexaenoic (22:6n-3)
2.1 ± 0.6 1.6 ± 0.2" 2.4 ± 0.2" 2.5 ± 0.5" 1.6 ± 0.3" 2.7 ± 0.5" 2.5 ± 0.3"
Total saturates 56.6 ± 2.2 54.4 ± 2.1 54.0 ± 1.5 52.4 ± 2.1 55.9 ± 2.4" 53.8 ± 2.6" 52.8 ± 1.5"
Total monounsaturates 14.1 ± 0.9 13.6 ± 1.5"
15.3 ± 0.7" 16.6 ± 0.7"
13.1 ± 1.0" 16.3 ± 0.5"
17.3 ± 0.4' Total n-3 polyunsaturates 5.6 ± 1.8
3.3 ± 0.6" 10.4 ± 0.9" 10.2 ± 1.3" 2.8 ± 0.6" 1 1.3 ± 1.6" 10.4 ± 1.2" Total n-6 polyunsaturates 23.7 ± 1.6 28.6 ± 0.9" 20.3 ± 0.6" 20.8 ± 1.0"
28.2 ± 2.8" 18.6 ± 1.1"
19.5 ± 0.6" n-6:n-3 4.7 ± 1.5 8.8 ± 1.4" 2.0 ± 0.2" 2.1 ± 0.3" 10.4 ± 2.3" 1.7 ± 0.? 1.9 ± 0.3" P:S2 change on day 6. In contrast, lungs from rats given diets B and C had significantly lower(P < 0.01) percentages ofAA by day 6 than did rats at baseline or rats given diet A. LA as well as ratios of n -6 to n -3 were also lower in rats given diets B and C relative to those given diet A (Table  4) . Rats given diet B (EPA + low GLA) experienced a greater (P < 0.05) reduction (29%) in lung AA between days 0 and 6 than did rats given diet C (14%). This reduction occurred in concert with the rise in the relative percentages of EPA and/or DHGLA.
The mean relative percentages of phospholipid EPA ( Figure  4) , DPA, DHA, and total n-3 PUFAs (Table  4) in lung tissue from rats given diets B and C were significantly higher (P < 0.001) than the corresponding means at baseline, as well as in lung tissue from rats given diet A on both day 3 and day 6. Diet groups B and C had similar percentages of individual and total n-3 PUFAs on day 3. The mean relative percentage of lung phospholipid DHGLA (1.3%) was significantly higher by day 3 in rats given diet C (ie, the EPA + high-GLA diet) in comparison with rats given either diet B (0.9%, P < 0.05) or diet A (0.8%, P < 0.0l)( Figure  4 ). Although lung DHGLA in the rats given diet C increased further to 1 .5% by day 6, there were no changes in lung DHGLA in the rats given diet B. GLA was not detected in any lung homogenates.
The resultant differences in the eicosanoid precursor ratio ( Figure  5 ) between the group of rats provided with diet A and those given either diet B or C for 3 d further exemplified the rapidity and extent of dietary modulation of these lung phospholipid PUFAs. Rats receiving diet B or C had a significantly higher eicosanoid precursor ratio than did rats at baseline or those given diet A. The ratio increased further between days 3 and 6 for rats given diet B or C. The Uls of lung phospholipid fatty acids from rats given diet B or C were also significantly higher (P < 0.001) on day 3 than those at baseline or those of rats given diet A ( Oleic (18:ln-9) 7.2 ± 1.6 7.8 ± 0.7 9.2 ± 3.2 9.7 ± 0.6 8.6 ± 2.5 10.1 ± 0.8 9.3 ± 1.8 Linoleic (18:2n-6) 11.7 ± 1.5 13.9 ± 2.3" 11.2 ± 0.9" 9.2 ± 0.8" 15.9 ± 1.8" 11.4 ± 0.4" 9.6 ± 1.2' Dihomo-y-linolenic (20:3n-6) 0.98 ± 0.39 0.80 ± 0.56" 1.43 ± 0.22" 2.58 ± 0.34' 1.12 ± 0.17" 1.42 ± 0.15" 2.13 ± 0.46' Arachidonic (20:4n-6) 15.8 ± 4.2 21.7 ± 2.4" 14.9 ± 0.8" 14.9 ± 1.8" 20.8 ± 1.2" 13.3 ± 1.7" 14.7 ± 2.4" Eicosapentaenoic (20:Sn-3) 1.5 ± 1.1 0.2 ± 0.3" 6.6 ± 1.8" 5.4 ± 1.8" 0.2 ± 0.4#{176} 8.5 ± 1.4" 4.7 ± 3.0 Docosapentaenoic (22:5n-3) 1.7 ± 0.6 0.5 ± 0.4" 3.8 ± 0.6" 3.7 ± 0.7" 0.3 ± 0.3" 4.0 ± 0.1" 3.1 ± 0.6" Docosahexaenoic (22:6n-3) 2.5 ± 0.7 2.1 ± 0.7" 3.0 ± 1.6" 4.0 ± 1.1" 3.2 ± 0.8 4.0 ± 1.0 3.6 ± 0.7
Total saturates 55.5 ± 5.1 49.3 ± 2.9 46.7 ± 1.8 47.5 ± 4.0 48.3 ± 1.9 44.7 ± 1.9 48.8 ± 5.7
Total monounsaturates 9.3 ± 2.3 9.9 ± 0.9 1 1.4 ± 2.7 1 1.8 ± 1.8 9.9 ± 2.6" 12.0 ± 0.5" 12.6 ± 2.3"
Total n-3 polyunsaturates 5.8 ± 1.8 2.8 ± 0.8" 13.5 ± 2.1" 13.5 ± 3.1" 3.7 ± 0.5" 16.6 ± 1.0" 1 1.5 ± 4.V'
Total n-6 polyunsaturates 29.1 ± 5.2 37.6 ± 3.0" 28.1 ± 1.6" 27.1 ± 2.5" 39.2 ± 2.8" 26.5 ± 1.6" 26.9 ± 2.2" n-6:n-3 5.6 ± 1.9
14.5 ± 5.7"
2.1 ± 0.3" 2.1 ± 0.5" 10.8 ± 1.2" 1.6 ± 0.1" 2.6 ± 1.0" P:S2 fatty acids X number of double bonds)/l00.
3, and by day 6 rats on diet B had a significantly higher mean ratio than rats given either diet A or diet C. The mean UIs of the KE cell phospholipids from the rats given diets B and C for 3 d were also significantly higher than those at baseline (P < 0.01 ) or those of rats given diet A (P < 0.05)( Table   5 ). This increased degree of unsaturation was sustained on day 6; however, differences between the UI of rats given diet A and those of rats given either diet B or C were not statistically significant (P < 0.08). The results for the lung (Table  4 ) and KE cell ( Figure  3 and Table  5 , respectively) and lung tissue 
DISCUSSION
